August 31, 2020 | HealthClot

Vessi Medical Reaps $1.7 Million in Funding for Minimally Invasive Bladder Cancer Treatment

By HealthClot Moderator
August 31, 2020
0

Vessi Medical Reaps $1.7 Million in Funding for Minimally Invasive Bladder Cancer Treatment MISGAV, Israel, Aug. 31, 2020 /PRNewswire/ — Vessi Medical, a portfolio company of The Trendlines Group Ltd. (SGX: 42T) (OTCQX: TRNLY) announced that it secured $1.7 million in funding for its cryoablation solution for superficial bladder cancer. Participating in the financing were […]

Karyopharm Therapeutics Appoints Christy J. Oliger to its Board of Directors

By HealthClot Moderator
August 31, 2020
0

Karyopharm Therapeutics Appoints Christy J. Oliger to its Board of Directors NEWTON, Mass., Aug. 31, 2020 /PRNewswire/ — Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced the appointment of Christy J. Oliger to its Board of Directors. Ms. Oliger is the former Senior Vice President of the Oncology Business […]

Blood Cancers Explained: Leukemia, Myeloma, Lymphoma, and more

By HealthClot Moderator
August 31, 2020
0

Blood Cancers Explained: Leukemia, Myeloma, Lymphoma, and more A short and simple video tutorial with animations, to help you gain a basic understanding of Leukemia, Myeloma, Lymphoma, Myelodysplastic syndrome, and the Myeloproliferative diseases including Myelofibrosis. These are the main diseases relating to cancers of the blood system (hematological malignancy) I will be covering each of […]

Plasma cell leukemia and extramedullary disease in multiple myeloma

By HealthClot Moderator
August 31, 2020
0

Plasma cell leukemia and extramedullary disease in multiple myeloma What is the current treatment landscape for plasma cell leukemia and extramedullary disease in multiple myeloma (MM)? We spoke to Niels van de Donk, MD, PhD, of VU University Medical Center, Amsterdam, Netherlands, about this at the European School of Haematology (ESH) International Conference on MM […]